AU2002300092B2 - New benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents

New benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them Download PDF

Info

Publication number
AU2002300092B2
AU2002300092B2 AU2002300092A AU2002300092A AU2002300092B2 AU 2002300092 B2 AU2002300092 B2 AU 2002300092B2 AU 2002300092 A AU2002300092 A AU 2002300092A AU 2002300092 A AU2002300092 A AU 2002300092A AU 2002300092 B2 AU2002300092 B2 AU 2002300092B2
Authority
AU
Australia
Prior art keywords
formula
group
optionally substituted
compounds
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002300092A
Other languages
English (en)
Other versions
AU2002300092A1 (en
Inventor
Bernard Cimetiere
Thierry Dubuffet
Gilbert Lavielle
Serge Simonet
Christine Vayssettes-Courchay
Tony Verbeuren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Publication of AU2002300092A1 publication Critical patent/AU2002300092A1/en
Application granted granted Critical
Publication of AU2002300092B2 publication Critical patent/AU2002300092B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/19—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
AU2002300092A 2001-07-13 2002-07-12 New benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them Ceased AU2002300092B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0109339A FR2827280B1 (fr) 2001-07-13 2001-07-13 Nouveaux derives de benzene sulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR01.09339 2001-07-13

Publications (2)

Publication Number Publication Date
AU2002300092A1 AU2002300092A1 (en) 2003-06-12
AU2002300092B2 true AU2002300092B2 (en) 2007-07-12

Family

ID=8865462

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002300092A Ceased AU2002300092B2 (en) 2001-07-13 2002-07-12 New benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them

Country Status (23)

Country Link
US (1) US6541471B1 (enExample)
EP (1) EP1275641B1 (enExample)
JP (1) JP3770858B2 (enExample)
KR (1) KR100503157B1 (enExample)
CN (1) CN1186318C (enExample)
AR (1) AR035257A1 (enExample)
AT (1) ATE286877T1 (enExample)
AU (1) AU2002300092B2 (enExample)
BR (1) BR0202685A (enExample)
CA (1) CA2393995C (enExample)
DE (1) DE60202554T2 (enExample)
DK (1) DK1275641T3 (enExample)
EA (1) EA005376B1 (enExample)
ES (1) ES2234994T3 (enExample)
FR (1) FR2827280B1 (enExample)
HU (1) HUP0202284A3 (enExample)
MX (1) MXPA02006853A (enExample)
NO (1) NO20023390L (enExample)
NZ (1) NZ520141A (enExample)
PL (1) PL355009A1 (enExample)
PT (1) PT1275641E (enExample)
SI (1) SI1275641T1 (enExample)
ZA (1) ZA200205597B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106083546A (zh) * 2016-06-20 2016-11-09 上海引盛生物科技有限公司 一种3,5‑二溴苯甲醛的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02304022A (ja) * 1989-05-18 1990-12-17 Mitsubishi Kasei Corp セロトニン拮抗剤
US5364866A (en) * 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
DE69129611T2 (de) * 1990-08-20 1998-12-17 Eisai Co., Ltd., Tokio/Tokyo Sulfonamid-Derivate
TW219358B (enExample) * 1991-12-20 1994-01-21 Hokuriku Pharmaceutical
GB9220137D0 (en) * 1992-09-23 1992-11-04 Pfizer Ltd Therapeutic agents
JPH0753505A (ja) * 1992-10-01 1995-02-28 Hokuriku Seiyaku Co Ltd ベンゼンスルホンアミド誘導体及びその用途
FR2760235B1 (fr) * 1997-02-28 1999-04-09 Adir Nouveaux derives de benzenesulfonylamine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
HUP0202284A3 (en) 2005-02-28
NO20023390D0 (no) 2002-07-12
ATE286877T1 (de) 2005-01-15
HUP0202284A2 (hu) 2003-02-28
FR2827280A1 (fr) 2003-01-17
NO20023390L (no) 2003-01-14
CA2393995C (fr) 2008-06-10
DE60202554T2 (de) 2005-12-29
HU0202284D0 (enExample) 2002-09-28
EP1275641B1 (fr) 2005-01-12
PT1275641E (pt) 2005-05-31
KR20030007174A (ko) 2003-01-23
DE60202554D1 (de) 2005-02-17
NZ520141A (en) 2003-11-28
EA005376B1 (ru) 2005-02-24
JP3770858B2 (ja) 2006-04-26
ES2234994T3 (es) 2005-07-01
SI1275641T1 (en) 2005-04-30
ZA200205597B (en) 2003-03-27
JP2003113156A (ja) 2003-04-18
EP1275641A3 (fr) 2003-05-14
CN1397547A (zh) 2003-02-19
MXPA02006853A (es) 2005-07-25
KR100503157B1 (ko) 2005-07-25
DK1275641T3 (da) 2005-04-25
EA200200666A1 (ru) 2003-02-27
CN1186318C (zh) 2005-01-26
AR035257A1 (es) 2004-05-05
PL355009A1 (en) 2003-01-27
CA2393995A1 (fr) 2003-01-13
FR2827280B1 (fr) 2003-10-31
BR0202685A (pt) 2003-05-06
US6541471B1 (en) 2003-04-01
EP1275641A2 (fr) 2003-01-15
HK1050675A1 (en) 2003-07-04

Similar Documents

Publication Publication Date Title
HUT72088A (en) Heterocyclic derivatives, pharmaceutical compositions containing them and process for producing them
WO1997029097A1 (en) Sulfonamide derivatives as 5ht7 receptor antagonists
JP2003517013A (ja) フェノキシプロパノールアミン類、それらの製造方法およびそれらを含む医薬組成物
HU199416B (en) Process for producing dichloro-anilin derivatives and pharmaceutical compositions containing them
AU593039B2 (en) Phenoxyalkylcarboxylic acids and esters and their preparation and pharmaceutical formulation
CN102175786A (zh) 氨基丙醇衍生物
JP3101677B2 (ja) ジフェニルピペラジン誘導体及びこれを含有する循環器用薬
JPH0692365B2 (ja) ピペリジンおよびピロリジン誘導体
US5574031A (en) Piperazine carboxamides
US6469011B2 (en) Benzenesulfonamide compounds useful as TXA2 and 5-HT2 receptor antagonists
AU2004213104B2 (en) Indazolamides with analgesic activity
AU2002300092B2 (en) New benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them
AU2002300093B2 (en) New benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them
FR2758329A1 (fr) Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique
WO1999062900A1 (fr) Derives d'oxindole utile comme antagonistes des recepteurs de neurokinines
US5071858A (en) Antipsychotic benzothiopyranylamines
JP2004506715A (ja) Ｎｍｄａ受容体リガンドに対するプロドラッグ
US2608559A (en) Tertiary- amino-l-aryl-l
WO1997003059A1 (en) 4-(substituted aminomethyl)thiazoline derivatives
JPWO2006038719A1 (ja) ホスホン酸誘導体及び血中の高リン酸が関与する疾患の治療剤
JPH06145136A (ja) 置換ベンゼンスルホンアミド誘導体
WO1991000275A1 (fr) Composes de butane ou leurs sels et leurs utilisations en medecine
JPWO1996013497A1 (ja) テトラヒドロイソキノリン誘導体およびそれを含有する医薬製剤

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired